ARCHIVES

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

This article is from The Cancer Letter archive.

Vol. 31 No. 22 | June 3, 2005

Download PDF Visit The Full Archive

Related Articles

Klausner, Nathan Discuss Challenge of Cancer Research In the “Post-Genome World”

January 15, 1999

NIH Seeks Comment On Reorg Plan For Oncology Study Sections

April 5, 2002

Moddelmog Steps Down At Komen For the Cure

November 20, 2009

Weicker Negotiating For 6,000 NIH Grants In Both 1985, 1986; Societies Appeal For Adequate Funding

May 10, 1985

Cancer Rates May Rise 50% By 2020, IARC Says

April 18, 2003

Sponsors Wanted: FDA Offers Incentives For Pediatric Oncology Drug Development.

March 10, 2000